Wambolt & Associates’s Evoke Pharma EVOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-222
| Closed | -$15K | – | 239 |
|
|
2022
Q1 | $15K | Hold |
222
| – | – | 0.01% | 237 |
|
|
2021
Q4 | $18K | Hold |
222
| – | – | 0.01% | 240 |
|
|
2021
Q3 | $39K | Hold |
222
| – | – | 0.02% | 239 |
|
|
2021
Q2 | $42K | Hold |
222
| – | – | 0.02% | 245 |
|
|
2021
Q1 | $59K | Hold |
222
| – | – | 0.03% | 214 |
|
|
2020
Q4 | $83K | Hold |
222
| – | – | 0.05% | 204 |
|
|
2020
Q3 | $150K | Hold |
222
| – | – | 0.11% | 177 |
|
|
2020
Q2 | $113K | Hold |
222
| – | – | 0.09% | 176 |
|
|
2020
Q1 | $37K | Hold |
222
| – | – | 0.04% | 158 |
|
|
2019
Q4 | $52K | Sell |
222
-8
| -3% | -$1.87K | 0.04% | 167 |
|
|
2019
Q3 | $29K | Hold |
230
| – | – | 0.02% | 157 |
|
|
2019
Q2 | $21K | Hold |
230
| – | – | 0.02% | 158 |
|
|
2019
Q1 | $24K | Hold |
230
| – | – | 0.02% | 151 |
|
|
2018
Q4 | $82K | Buy |
+230
| New | +$82K | 0.09% | 143 |
|